Failure to thrive in children with tubulopathies increases the risk of overweight later in life.
Journal
International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108
Informations de publication
Date de publication:
16 Sep 2023
16 Sep 2023
Historique:
received:
12
07
2023
accepted:
11
09
2023
revised:
06
09
2023
medline:
17
9
2023
pubmed:
17
9
2023
entrez:
16
9
2023
Statut:
aheadofprint
Résumé
Failure to thrive (FTT) is an inadequate growth in young children. It can increase the risk of overweight or obesity later in life. Patients with renal tubulopathies can present FTT due to solute losses in the urine. We aimed to test our hypothesis that children with tubulopathies have an increased risk of overweight and obesity due to rebound following FTT that could complicate these conditions. We enrolled 26 patients with tubulopathies and evaluated for the first time within the first 12 months of life (mean age: 4.8 months ± 2.6 SDS). FTT was evident in 17 out of 26 patients (65.4%). The mean age at the last follow-up was 14.1 years ± 5.5 SDS. The mean age at overweight/obesity onset was 9.0 years ± 3.6 SDS. The prevalence of overweight/obesity was 73.1% (19/26). Among the patients with FTT, 15 (88.2%) developed overweight/obesity compared to 4 out of the 9 patients (44.4%) without FFT (p = 0.028). The presence of FTT determined an OR for obesity/overweight of 9.4 (95% CI: 1.3-67.6; p = 0.026). FTT continued to be significantly associated with obesity/overweight also after adjustment for preterm birth and birth weight <10th percentile (OR = 23.3; 95% CI: 1.95-279.4; p = 0.01). In conclusion, in our series, patients with tubulopathies presented an increased risk of overweight/obesity due to the FTT that can complicate these conditions.
Identifiants
pubmed: 37717124
doi: 10.1038/s41366-023-01386-2
pii: 10.1038/s41366-023-01386-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Kliegman RM, Stanton BMD, Geme J St., Schor NF, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier Inc; 2016.
Kim GJ, Furman LM. Obesity outcomes in children with a history of failure to thrive. Clin Pediatr. 2014;53:603–4.
doi: 10.1177/0009922813488650
Vijay Kiran B, Barman H, Iyengar A. Clinical profile and outcome of renal tubular disorders in children: a single center experience. Indian J Nephrol. 2014;24:362–6.
doi: 10.4103/0971-4065.133002
pubmed: 25484529
pmcid: 4244715
Mrad FCC, Soares SBM, de Menezes Silva LAW, dos Anjos Menezes PV, Simões-e-Silva AC. Bartter’s syndrome: clinical findings, genetic causes and therapeutic approach. World J Pediatr. 2021;17:31–9.
doi: 10.1007/s12519-020-00370-4
pubmed: 32488762
Alexander RT, Law L, Gil-Peña H, Greenbaum LA, Santos F. Hereditary distal renal tubular acidosis. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews®. Seattle: University of Washington; 2019. https://www.ncbi.nlm.nih.gov/books/NBK547595/ .
Leung T, Babbitt C, O’Brien K. Severe hypernatremia and failure to thrive. Clin Pediatr. 2016;55:1085–7.
doi: 10.1177/0009922816664069
La Scola C, Guarino S, Pasini A, Capalbo D, Liguori L, Di Sessa A, et al. Effect of body mass index on estimated glomerular filtration rate levels in children with congenital solitary kidney: a cross-sectional multicenter study. J Ren Nutr. 2020;30:261–7.
doi: 10.1053/j.jrn.2019.07.003
pubmed: 31500951
Indagine nazionale 2019: i dati nazionali. 2019. https://www.epicentro.iss.it/okkioallasalute/indagine-2019-dati .
Thoene JG. Cystinosis. J Inherit Metab Dis. 1995;18:380–6.
doi: 10.1007/BF00710050
pubmed: 7494397
Becue C, Ceuleers B, den Brinker M, Somers I, Ledeganck KJ, Dotremont H, et al. Screening for an underlying tubulopathy in children with growth failure, simply maths? Front Pediatr. 2022;10:902252.
doi: 10.3389/fped.2022.902252
pubmed: 35911830
pmcid: 9334702
Kleta R, Bockenhauer D. Salt-losing tubulopathies in children: what’s new, what’s controversial? J Am Soc Nephrol. 2018;29:727.
doi: 10.1681/ASN.2017060600
pubmed: 29237739
Elmonem MA, Veys KR, Soliman NA, Van Dyck M, Van Den Heuvel LP, Levtchenko E. Cystinosis: a review. Orphanet J Rare Dis. 2016;11:47.
doi: 10.1186/s13023-016-0426-y
pubmed: 27102039
pmcid: 4841061
Blanchard A, Curis E, Guyon-Roger T, Kahila D, Treard C, Baudouin V, et al. Observations of a large Dent disease cohort. Kidney Int. 2016;90:430–9.
doi: 10.1016/j.kint.2016.04.022
pubmed: 27342959
Al-Awqati Q. Basic research: salt wasting in distal renal tubular acidosis-new look, old problem. Nat Rev Nephrol. 2013;9:712–3.
doi: 10.1038/nrneph.2013.235
pubmed: 24189652
Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol. 2011;26:1789–802.
doi: 10.1007/s00467-011-1871-4
pubmed: 21503667
pmcid: 3163795
Liu C, Wu B, Lin N, Fang X. Insulin resistance and its association with catch-up growth in Chinese children born small for gestational age. Obesity. 2017;25:172–7.
doi: 10.1002/oby.21683
pubmed: 27865057
Luther JM. Effects of aldosterone on insulin sensitivity and secretion. Steroids. 2014;91:54–60.
doi: 10.1016/j.steroids.2014.08.016
pubmed: 25194457
Hales CN, Barker DJP. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5–20.
doi: 10.1093/bmb/60.1.5
pubmed: 11809615
Lopez-Garcia SC, Downie ML, Kim JS, Boyer O, Walsh SB, Nijenhuis T, et al. Treatment and long-term outcome in primary nephrogenic diabetes insipidus. Nephrol Dial Transplant. 2020;gfaa243. https://doi.org/10.1093/ndt/gfaa243.